These results suggest a novel regulatory axis of miR‐27a‐3p–Sfrp1 in modulating BMSC osteogenesis, which sheds new light in the clinical diagnosis and treatment of osteoporosis. The gene discussed is SFRP1; the disease is osteoporosis.